Evidence map›Paper›PMID 41593817›Full record

ArticleBioelectronic medicine2026

The sixth bioelectronic medicine summit: Neurotechnologies for individuals and communities.

Siyar Bahadir, Jacob T Robinson, Leslie R Morse, Paul B Yoo, Ralph Kern, Nathan S Makowski, Takashi D Y Kozai, Marat Fudim, Mary F Barbe, Hubert H Lim and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioelectronic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siyar BahadirInstitute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Jacob T RobinsonDepartment of Electrical and Computer Engineering and Rice Neuroengineering Initiative, Rice University, Houston, TX, USA.
Leslie R MorseDepartment of Physical Medicine and Rehabilitation, University of Miami Miller School of Medicine, Miami, FL, USA.
Paul B YooInstitute of Biomedical Engineering, University of Toronto, and KITE Research Institute, Toronto Rehabilitation Institute-University Health Network, Toronto, ON, Canada.
Ralph KernCognito Therapeutics, Cambridge, MA, USA.
Nathan S MakowskiDepartment of Physical Medicine and Rehabilitation, MetroHealth System and Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Takashi D Y KozaiDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
Marat FudimDivision of Cardiology, Duke University School of Medicine, and Duke Clinical Research Institute, Durham, NC, USA.
Mary F BarbeDepartment of Cardiovascular Sciences, Lewis Katz School of Medicine, Aging + Cardiovascular Discovery Center, Temple University, Philadelphia, PA, USA.
Hubert H LimDepartments of Biomedical Engineering and Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN, USA.
Eric H ChangInstitute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Stavros ZanosInstitute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA. szanos@northwell.edu.

Funding

NIH HHS NIH-NIGMS R01GM143362NIH HHS NIH-NINDS 1R01NS136685NIH HHS NIH SPARC U41 - NS129436
6 · The paper itself

Abstract

The Sixth Bioelectronic Medicine Summit took place on March 4 and 5, 2025 at the Garden City Hotel in New York, and was co-hosted by the Feinstein Institutes for Medical Research (FIMR), Northwell Health and the University of Minnesota. The Summit brought together speakers and attendees from academia, medicine and industry to discuss the evolving landscape of neuromodulation and bioelectronic therapeutics. This year’s Summit was titled “Neurotechnologies for Individuals and Communities” and emphasized approaches that consider differences between subjects to deliver precision neuromodulation therapies, as well as approaches that expand the therapeutic footprint of neuromodulation to underserved populations and communities. The Summit included sessions covering basic and translational research, device development and commercialization, and emerging clinical applications. This meeting report summarizes the major events from the two days of the Summit, including keynote addresses, scientific sessions, discussion panels, award presentations, and sponsored talks.

Indexed as

Autonomic nervous systemBioelectronic medicineBioresorbable electronicsBrain–computer interfacesClosed-loop stimulationGamma-frequency sensory stimulationGut–brain axisHeart failure with preserved ejection fractionLow-intensity pulsed ultrasound (LIPUS)MicrobiomeNeuroimmune modulationNeuromodulationPelvic and bladder neuromodulationPrecision neuromodulationSPARC programSpinal cord injurySpinal cord stimulationTranscutaneous spinal cord stimulationTraumatic brain injuryVagus nerve stimulation

Identifiers

PMID41593817
PMCPMC12849451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.